相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Global Dissemination of Carbapenemase-Producing Klebsiella pneumoniae: Epidemiology, Genetic Context, Treatment Options, and Detection Methods
Chang-Ro Lee et al.
FRONTIERS IN MICROBIOLOGY (2016)
Frequency of antibiotic application drives rapid evolutionary adaptation of Escherichia coli persistence
Bram Van den Bergh et al.
NATURE MICROBIOLOGY (2016)
Activity of Antimicrobial Combinations against KPC-2-Producing Klebsiella pneumoniae in a Rat Model and Time-Kill Assay
Paula Virginia Michelon Toledo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Unravelling of a mechanism of resistance to colistin in Klebsiella pneumoniae using atomic force microscopy
C. Formosa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Large Nosocomial Outbreak of Colistin-Resistant, Carbapenemase-Producing Klebsiella pneumoniae Traced to Clonal Expansion of an mgrB Deletion Mutant
Tommaso Giani et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2015)
Collateral Resistance and Sensitivity Modulate Evolution of High-Level Resistance to Drug Combination Treatment in Staphylococcus aureus
Mari Rodriguez de Evgrafov et al.
MOLECULAR BIOLOGY AND EVOLUTION (2015)
Functional synergy of α-helical antimicrobial peptides and traditional antibiotics against Gram-negative and Gram-positive bacteria in vitro and in vivo
Q. Feng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)
In Vitro Synergistic Activities of Antimicrobial Peptide Brevinin-2CE with Five Kinds of Antibiotics Against Multidrug-Resistant Clinical Isolates
Yuan Zhang et al.
CURRENT MICROBIOLOGY (2014)
De novo generation of short antimicrobial peptides with enhanced stability and cell specificity
Hyun Kim et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii
Brooke A. Napier et al.
MBIO (2013)
When the Most Potent Combination of Antibiotics Selects for the Greatest Bacterial Load: The Smile-Frown Transition
Rafael Pena-Miller et al.
PLOS BIOLOGY (2013)
In Vivo Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae and Escherichia coli
Teresa Spanu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
In Vitro Activities of Antibiotics and Antimicrobial Cationic Peptides Alone and in Combination against Methicillin-Resistant Staphylococcus aureus Biofilms
Emel Mataraci et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data
Matthew Kearse et al.
BIOINFORMATICS (2012)
Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe
R. Canton et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
The Human Lactoferrin-Derived Peptide hLF1-11 Exerts Immunomodulatory Effects by Specific Inhibition of Myeloperoxidase Activity
Anne M. van der Does et al.
JOURNAL OF IMMUNOLOGY (2012)
The Antimicrobial Peptide hLF1-11 Drives Monocyte-Dendritic Cell Differentiation toward Dendritic Cells That Promote Antifungal Responses and Enhance Th17 Polarization
Anne M. van der Does et al.
JOURNAL OF INNATE IMMUNITY (2012)
Stimulation of suicidal death of erythrocytes by rifampicin
Majed Abed et al.
TOXICOLOGY (2012)
Overview of the epidemiology and the threat of Klebsiella pneumoniae carbapenemases (KPC) resistance
Luke Chen et al.
Infection and Drug Resistance (2012)
Plasmid-Mediated Resistance in Enterobacteriaceae
Constance Schultsz et al.
DRUGS (2011)
Antimicrobial Peptides - Promising Alternatives to Conventional Antibiotics
Sylvia A. Baltzer et al.
JOURNAL OF MOLECULAR MICROBIOLOGY AND BIOTECHNOLOGY (2011)
Global Spread of Carbapenemase-producing Enterobacteriaceae
Patrice Nordmann et al.
EMERGING INFECTIOUS DISEASES (2011)
The human lactoferrin-derived peptide hLF1-11 primes monocytes for an enhanced TLR-mediated immune response
Anne M. van der Does et al.
BIOMETALS (2010)
An Outbreak of Infection due to β-Lactamase Klebsiella pneumoniae Carbapenemase 2-Producing K-pneumoniae in a Greek University Hospital: Molecular Characterization, Epidemiology, and Outcomes
Maria Souli et al.
CLINICAL INFECTIOUS DISEASES (2010)
Synergy among antibacterial peptides and between peptides and small-molecule antibiotics
Marco Cassone et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2010)
Emerging carbapenemases: a global perspective
Timothy R. Walsh
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2010)
A simple phenotypic method for the differentiation of metallo-β-lactamases and class A KPC carbapenemases in Enterobacteriaceae clinical isolates
Athanassios Tsakris et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
In Vitro Evaluation of Antibiotic Synergy for Polymyxin B-Resistant Carbapenemase-Producing Klebsiella pneumoniae
Azza Elemam et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
The Combination of Rifampin plus Moxifloxacin Is Synergistic for Suppression of Resistance but Antagonistic for Cell Kill of Mycobacterium tuberculosis as Determined in a Hollow-Fiber Infection Model
G. L. Drusano et al.
MBIO (2010)
Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America
Helen W. Boucher et al.
CLINICAL INFECTIOUS DISEASES (2009)
Multifunctional Antimicrobial Proteins and Peptides: Natural Activators of Immune Systems
Francois Niyonsaba et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Attributable Mortality Rate for Carbapenem-Resistant Klebsiella pneumoniae Bacteremia
Abraham Borer et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2009)
Lactoferrin: structure, function and applications
Susana A. Gonzalez-Chavez et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Has the era of untreatable infections arrived?
David M. Livermore
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Multiplex Real-Time PCR for Rapid Staphylococcal Cassette Chromosome mec Typing
Liang Chen et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2009)
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
Patrice Nordmann et al.
LANCET INFECTIOUS DISEASES (2009)
Potential of immunomodulatory host defense peptides as novel anti-infectives
Donna M. Easton et al.
TRENDS IN BIOTECHNOLOGY (2009)
Human antimicrobial peptides' antifungal activity against Aspergillus fumigatus
A. Lupetti et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2008)
Tigecycline for the treatment of multidrug-resistant Enterobacteriaceae: a systematic review of the evidence from microbiological and clinical studies
Theodoros Kelesidis et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Scope and limitations of the designer proline-rich antibacterial peptide dimer, A3-APO, alone or in synergy with conventional antibiotics
Marco Cassone et al.
PEPTIDES (2008)
Accelerated evolution of resistance in multidrug environments
Matthew Hegreness et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Human lactoferrin-derived peptide's antifungal activities against disseminated Candida albicans infection
Antonella Lupetti et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Design of antimicrobial compounds based on peptide structures
Christian Appelt et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
The synthetic n-terminal peptide of human lactoferin, hLF(1-11), is highly effective against experimental infection caused by multidrug-resistant Acinetobacter baumannii
L Dijkshoorn et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Radiolabelled antimicrobial peptides for infection detection
A Lupetti et al.
LANCET INFECTIOUS DISEASES (2003)
Synergistic activity of the N-terminal peptide of human lactoferrin and fluconazole against Candida species
A Lupetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Development of novel antibacterial peptides that kill resistant isolates
M Cudic et al.
PEPTIDES (2002)
Synergistic interactions between mammalian antimicrobial defense peptides
H Yan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
H Yigit et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria
PH Nibbering et al.
INFECTION AND IMMUNITY (2001)
Candidacidal activities of human lactoferrin peptides derived from the N terminus
A Lupetti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Surface expression of lactoferrin by resting neutrophils
LV Deriy et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
